CONMED (CNMD) Earnings And Revenues Beat Estimates In Q4
Zacks Investment Research | Jan 30, 2020 09:37PM ET
CONMED Corporation (NASDAQ:CNMD) reported fourth-quarter 2019 adjusted earnings per share of 90 cents, which beat the Zacks Consensus Estimate of 89 cents by 1.1%. Further, the figure improved 23.3% from the year-ago quarter.
The New York-based medical products manufacturer reported revenues of $264.9 million, up 9.2% on a year-over-year basis and 9.3% at constant currency (cc). Notably, the figure surpassed the Zacks Consensus Estimate by 0.01%.
2019 at a Glance
In 2019, the company reported revenues worth $955.1 million, which improved 11.1% from the previous year.
Adjusted EPS for the year was $2.64, which improved 21.1% from 2018.
Segment Details
Orthopedic Surgery
Revenues in the segment totaled $123.8 million, down 0.8% from the year-ago quarter.
Both domestically and on international basis Orthopedics revenue fell 0.8% from their respective prior-year quarter's levels.
General Surgery
Revenues in the segment totaled $141.1 million, up 19.9% year over year.
Domestically, General Surgery sales improved 23.1% year over year and international sales advanced 14%.
Sales by Geography
In the reported quarter, sales in the United States amounted to $142.5 million, up 13.8% year over year. International sales improved 4.4% to $122.4 million.
CONMED Corporation Price, Consensus and EPS Surprise
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.